Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
Status:
Recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two medications that reverse muscle paralysis at the
end of kidney transplant surgery with the goal of reducing residual muscle weakness and
insufficient respiratory function after surgery.